Dr. Bassim AL Bahrani, is a renowned Medical oncology in the Sultanate of Oman who was the previous Director of National oncology center. He has a vast experience in the field for over 25 years. Part time Consultant Medical Oncologist and chief operating officer at the Gulf International Cancer Center. Working as Senior Consultant Medical Oncologist, Royal Hospital Muscat, Oman, and a visiting Professor at the Postgraduate Program on Health Economics, Management and Policy at the University of Peloponnese in Corinth, Greece. Worked as the Director of the National Oncology Center, Oman, Royal Hospital Oman for 9 years until December 2018. Done his advanced training in Medical Oncology in Australia and earned a fellowship from the Royal Australasian College of Physicians. He is an honorary Fellow of the Royal College of physicians and surgeons of Glasgow and Ph.D. from the University of Rome Tor Vergata. Chairman of the Ministry of Health Oman, and Royal Hospital Scientific and Research Committee, and deputy Chairman, Royal Hospital, Oman Scientific and Research Committee. Member of many Oncology associations, including the European Society of Medical Oncology, American Society of Clinical Oncology, Gulf Federation for Cancer Control, and Medical Oncology group of Australia.
Meteb Al-Foheidi, Saudi Arabia
Meteb Al-Foheidi
Medical Oncology Consultant – Breast Cancer Sub-specialty
Princess Noorah Oncology Center – National Guard Health Affairs, Jeddah
Assistant Professor & Medical Oncology Block Cordinator
King Saud Bin Abdulaziz University for Health and Science – Jeddah
Dr. Annett Al-Hamadi is a consultant in general and breast surgery. She is a German board certified general surgeon and European board certified breast surgeon.
Dr. Annett Al-Hamadi has more than 18 years of experience in the field of general surgery and breast surgery. As a native German, she graduated from the Martin-Luther-University Halle-Wittenberg, Germany and undertook Breast surgical training including a fellowship in the Brustzentrum Zuerich, Switzerland. She worked in Germany till 2006 where she was Consultant General Surgeon in the Berufsgenossenschaftliche Kliniken Halle.
In 2006 she moved to Dubai with her family and spent two years working at Rashid Hospital before joining Mediclinic City Hospital Breast Cancer Center in 2008.
Dr. Basel Altrabulsi , Chief Medical Officer and ICAD Laboratory Medical Director, graduated from the Medical School of Damascus University in 1996, spending his internship and pathology residency at Baylor University Medical Center in Dallas, Texas from 1999 to 2003, becoming Chief Resident in 2001. Dr. Altrabulsi completed his Surgical Pathology Fellowship followed by a Clinical Research Training Program at the University of Texas, M.D. Anderson Cancer Center in 2004, and received his American Board of Pathology in Anatomic and Clinical Pathology Certification in July 2004.
In addition to serving as CAP Inspection Team Leader, his professional career has included leadership positions in several laboratories across the USA, having served as Chief of Service and Medical Director at the Baylor University Medical Center (Waxahachie, Texas), Anatomical, Clinical Pathology and Laboratory Services from 2004 to 2007; Director of the Histology Laboratory at Greater Dallas Pathology between 2008 and 2010, and Medical Director of the Arlington Cancer Center (2008-2011). and the Laboratory Corporation of America, Southwest Division.
Dr Fathi Azribi is a Consultant Medical Oncologist. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies, with expertise in treatment with chemotherapy, immunotherapy, hormonal, and targeted therapy. He published several papers and abstracts in peer reviewed journals. He also founded the first Medical Oncology Fellowship program in the UAE.
Dr. Khalid Balaraj was initially trained in the United Kingdom. He has radiation oncology qualifications from UK (FRCR (I), Ireland (FFR RCSI) and Canada (FRCPC). He has done 2 Clinical Fellowships from Canada, in Gynecology Brachytherapy and CNS Stereotactic Radiotherapy. Currently, Dr. Khalid Balaraj is a consultant radiation oncologist at Tawam Hospital, Abu Dhabi, UAE.
Dr. Nouri Bennini, has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr. Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.
Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996. He continued his studies at the University of Navarra, specialising in Medical Oncology at the Clínica Universitaria de Navarra, where he continued as Assistant in the Department of Oncology from 2002. He was Associated Professor of Oncology in the Faculty of Medicine at the University of Navarra during that period. Dr. Cortés was awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. Since 2003, he has worked in the Department of Medical Oncology at the Hospital Vall d’ Hebron, Barcelona, where he is Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in the Area of Breast Cancer with a special interest in New Drugs Development. Dr. Cortés is Head of the Breast Cancer Unit and the Melanoma Unit.
In addition, he has two masters’ degree: “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
Dr. Cortes is the author of more than 100 publications, especially about breast tumours and new drugs and more than 250 communications at different conferences. He actively participates in the development of numerous national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents, and he is an ad hoc reviewer of various oncology journals.
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO), a member of the Scientific Committee of the European Society of Medical Oncology and the Scientific Committee of SOLTI group.
Dr. Kaltar Das is a senior specialist oncologist in Dubai academic and health corporation (formerly DHA) since more than a decade. He has done his internal medicine fellowship in 2008 and medical Oncology fellowship in 2011. He continued his clinical and academic excellence and achieved membership of American college of physicians, royal college of physicians and surgeons Glasgow and specialty certification in medical oncology from Royal college of physician UK. He worked on different positions in Pakistan, Qatar and in UAE.
Dr. Shaheenah Dawood’s specialty is Oncology and currently works as a Consultant Oncologist in Mediclinic City Hospital. She currently serves as president of the Excellence in Oncology Care (EIOC) congress that is held annually in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS) & APGCS.
Dr. Richard De Boer completed his basic medical and oncology training at the Royal Melbourne Hospital and then in 1997 undertook a 3-year breast and lung cancer clinical research fellowship at the Royal Marsden Hospital in London, working with Professor Ian Smith.
He returned to Melbourne in 2000 and since then has been a consultant medical oncologist working in both public and private practice. His primary areas of clinical interest are in breast and lung cancer, with breast cancer interests focusing on endocrine therapy and mechanisms of resistance, treatment-induced bone loss and bone metastases, and biological predictors of response/survival. He is actively involved in clinical research, and is a member of the Australian New Zealand Breast Cancer Trials Group, and head of the Breast Trials group of Cancer Trials Australia. He has authored or co-authored articles appearing in journals such as the Journal of Clinical Oncology, Annals of Oncology, The Breast and British Journal of Cancer.
Dr. Abdul Rahman Agha El Kinge
Adult Hematologist / Medical Oncologist
Dr. El Kinge completed his postdoctoral studies in Internal Medicine and fellowship in Hematology / Oncology at the American University of Beirut Medical Center. He was trained in Breast Cancer in MD Anderson Cancer Center and he is certified by the European Society of Medical Oncology.
Dr. El Kinge is adjunct clinical professor in University of Sharjah. He is on the editorial board and a reviewer in multiple international medical journals. He is a Fellow of the American College of Physicians, and a member of local and international Hematology and Oncology Societies. He has multiple peer-reviewed publications.
He is currently Head of the Department of Hematology / Medical Oncology In Fakeeh University Hospital, Dubai, UAE.
Dalia Elshourbagy
Consultant medical Oncology DAHC
Ass. Prof. Tanta University Hospital Egypt
Master Clinical oncology 2001
PhD clinical Oncology 2008
Dr. Fady Geara MD, PhD, is Department Chair of Radiation Oncology at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Geara served as Professor and Chairman of Radiation Oncology at the American University of Beirut Medical Center, Lebanon, after having been recruited from the University of Texas MD Anderson Cancer Center in Houston, Texas, US.
Dr. Geara received his medical degree from the University of Paris XI, France, and completed his residency and fellowship at the University of Texas MD Anderson Cancer Center in Houston, Texas, US.
Throughout his tenure, Dr. Geara has developed many state-of-the-art radiation oncology procedures. He developed the first high dose rate brachytherapy program in the Middle East, as well as the first Stereotactic Radiosurgery program. Over the years, Dr. Geara has become established as both a regional and international leader within his specialty.
Dr. Stephen R. Grobmyer, MD, is the Institute Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Grobmyer was Professor of Surgery, Section Head of Breast Surgery and Co-Director of the Cleveland Clinic Comprehensive Breast Cancer Program at Cleveland Clinic Main Campus in Cleveland, Ohio, USA.
Dr. Grobmyer received his medical degree from the University of Texas Southwestern Medical School in Dallas, Texas and completed his residency in General Surgery at New York Hospital-Cornell Medical Center in New York. He completed a fellowship in Surgical Oncology at Memorial Sloan Kettering in 2004.
Dr. Grobmyer’s innovative clinical care and research focuses on developing new approaches to prevent, diagnose and treat breast cancer. He has published over 200 peer-reviewed manuscripts and 20 book chapters. Additionally, he has given over one hundred invited lectures nationally and internationally.
Dr. Grobmyer has been the recipient of numerous prestigious awards including, The Lester Dragstedt Physician Scientist Award, The Society of Surgical Oncology Clinical Investigator Award and The American College of Surgeons Japan Travelling Fellowship. He is a member of the American Surgical Association. His influential clinical care and research has been featured widely in the Unites States media including NBC Nightly News, MSNBC, National Public Radio, The New York Times and Vogue.
Dr. Gurunian received his medical degree from Marmara University School of Medicine, Istanbul, 1991 and completed his plastic surgery residency at the same university in 1997. Dr. Gurunian then continued his training in the U.S.A. and completed a 1-year Microsurgery Fellowship, Department of Plastic and Reconstructive Surgery, Cleveland Clinic Foundation, Ohio, 2000-2001. He further trained for one year in Innsbruck, Austria, at the department of Plastic Surgery, specializing in breast reconstruction and reconstructive microsurgery. Dr. Gurunian received his PhD completing Doctorate in Anatomy, Istanbul 2003.
Dr. Gurunian became the chief plastic surgeon at Denver Medical Center, University of Colorado Health Sciences in 2006. His focus and interest were breast reconstruction and head and neck reconstruction.
In 2014, Dr. Gurunian appointed as staff physician at the department of Plastic and Reconstructive Surgery, Cleveland Clinic, Ohio. He was one of the transplant surgeons performing the first total face transplant in the U.S.A (3rd face transplant at Cleveland Clinic), May 4-5, (2017).
In 2021, Dr. Gurunian appointed as the chief of Plastic Surgery at Cleveland Clinic Abu Dhabi. He continues to have Medical Staff reappointment and privileges at the Cleveland Clinic Main Campus. In Cleveland Clinic Abu Dhabi, he pioneered breast reconstruction and lymphatic surgery introducing this niche service to UAE for the first time.
Dr. Gurunian is an American board and European board-certified plastic surgeon and a professor of Plastic Surgery at Cleveland Clinic Lerner college of Medicine of Case Western Reserve University. Dr. Gurunian has practiced in Europe, in the USA, and in the middle East and has vast experience in plastic surgery, especially in the field of breast surgery, breast reconstruction, reconstructive microsurgery and vascularized tissue allotransplantation.
Throughout his career, Dr. Gurunian has performed over 12,000 operations. He has published over 150 articles in peer reviewed scientific journals and is the lead editor of two plastic surgery books. On multiple occasions, he has been invited to national and international meetings as a lecturer and panelist.
Dr. Tibor G. Kovacs, MD, is Chief of Breast Surgery in the Digestive Disease Institute at Cleveland Clinic Abu Dhabi.
Prior to joining Cleveland Clinic Abu Dhabi, Dr. Kovacs was Director of Breast Health, Chief of Breast Surgery at Jiahui International Hospital and Honorary Professor at Fudan University Cancer Centre, Shanghai, China.
Dr. Kovacs received his medical degree from the University of Medicine and Pharmacy in Cluj, Romania. He completed his residency and Surgical Oncology fellowship at the National Institute of Oncology, Budapest, Hungary and a fellowship in Oncoplastic and Reconstructive Breast Surgery at the University Hospital of South Manchester, and Royal University Hospital Liverpool, UK.
Dr. Kovacs is a European Board Certified (FEBS) Surgical Oncologist and Breast Surgeon, a leading expert in breast cancer and reconstructive surgery with a vast experience in oncoplastic breast conservation, breast reconstruction and risk reduction breast surgery.
.
Aladdin Maarraoui, MD, FACP
Dr. Maarraoui is Consultant and Chief of Hematology/Oncology at Gulf International Cancer Center in Abu Dhabi and Clinical Professor at Gulf Medical University, UAE. He previously served as Chief of Hematology/Oncology at Mafraq Hospital for 14 years. He graduated from Faculty of Medicine at Aleppo University/Syria. He did his Internal Medicine residency at Christ Hospital and Medical Center in Chicago, and his Hematology/Oncology fellowship at the University of Colorado Health Science Center in Denver, Colorado. He is American Board Certified and recertified in Internal medicine in 1992, 2002, 2012 and 2022, in Medical Oncology in 1999,2009 and 2019 and in Hematology in 1999, 2009 and 2019. Dr. Maarraoui authored and co-authored several abstracts and articles on Breast Cancer, Colon Cancer, Thyroid Cancer, lung cancer and Lymphoma focusing on these diseases in UAE.
.
Rana Irfan Mahmood
Dr Rana Mahmood completed specialist clinical oncology training in UK and has been a consultant for last 16 years. He had several managerial roles and most recently was clinical director for cancer services across East Suffolk and North Essex (ESNEFT NHS trust). He is a passionate teacher and currently is associate professor at MBR University of Medicine and Health Sciences in Dubai.
Dr Mahmood has special interest in advance image guided radiotherapy (IM-IGRT), Stereotactic radiotherapy (SABR) and image adapted High Dose rate Brachytherapy (HDR). He has been principal investigator for several landmark radiotherapy trials including STAMPEDE, RADICALS, CHHiP, PACE, RAIDER and EMBRACE and he has extensively published his work.
Prof. Bruce Mann is Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient.
Mohsen Mokhtar Cairo, Egypt
Mohsen Mokhtar is Professor of Clinical Oncology at the Cairo University Kasr El Aini Medical School in Egypt.
He also collaborated to several regional and international trials. With interest in Lung Breast and Gynaecological Malignancies
He published more than 60 publications on these topics in regional and international medical journals.
Professor Mokhtar is the President of CANSURVIVE a NGO for Cancer Patient Support
Member of ASCO ESMO AMAAC
Dr. Sonia Otsmane is a Medical Oncology Hematology physician MD at Cleveland Clinic, Abu Dhabi, UAE
Dr. Asif Quadri is a Consultant Anatomical and Cytopathologist, who joined National Reference Laboratory after working as Consultant and Chief of Anatomical Pathology, at Tawam Hospital, the regional cancer center in the UAE, for seven years. Prior to that he worked as a Consultant Anatomical Pathologist for five years at City Hospital, Sandwell and West Birmingham NHS Trust, UK.
Dr. Asif’s special interests include: Biomarkers, gynecological pathology, breast pathology and lung tumors.
After completing his medical degree at the College of Medicine, University of Baghdad, in Iraq, Dr. Asif pursued his pathology residency training in the UK. He was awarded a Certificate of Completion in Specialist Training (CCT) for Anatomical Pathology and Cytopathology from the Postgraduate Medical and Education Training Board and General Medical Council, in the UK, and is a Fellow of the Royal College of Pathologists, London. His interest in medical education earned him a Postgraduate Certificate in Medical Education from University of Staffordshire, UK.
Dr. Asif is a College of American Pathologists (CAP) accreditation inspection team member. He is also a regional expert and trainer for companion diagnostic immunochemistry for PDL1 biomarker clones.
He has been published in numerous professional journals and frequently presents cases and papers at local and regional meetings.
Dr. Aly Abdel Razek graduated from Cairo University. He completed his residency at Washington University in St. Louis, Mo., USA. He is board certified in both Radiation Oncology and Pediatrics. He co-authored four text books in radiation oncology and contributed to many publications in oncology journals.
He served on the national committee of the Southwest Oncology Group, Intergroup Ewings Sarcoma and National Wilms Tumor Committee.
Dr. Abdel Razek is a Fellow of the American College of Radiation Oncology.
He is president of Medical Resources International and Chairman and Executive Director of the Gulf International Cancer Center.
Schlomo Schneebaum
I am a professor of surgery at Tel Aviv University, Tel Aviv, Israel, and the president of the Israeli Senologic Society. And President of the International Senologic Society
My residency I did in Sheba Medical Center, Israel, and surgical oncology fellowships at the University of Illinois in Chicago, Illinois, and at Ohio State University in Columbus, Ohio, where I also practiced as an attending surgeon thereafter.
I was Head of the Radio-Guided Surgery Unit in Tel Aviv Medical Center, Tel Aviv, Israel, and Head of the Breast Health Center which under my guidance was the first center to receive Breast Cancer Center International accreditation. And now an attending Surgeon at the department of surgery.
I was the Head of Surgery in Tel Aviv University, President of the Israeli Surgical Oncology Society.
I had experience in European Societies was a member of the board of ESSO (European Surgical Oncology Society),FECS (federation of European cancer societies ), and served as Head of Surgical Oncology in the UMES (Union Medical European Specialists).
I was a member of the SIS board as General Secretary and as Vice President for Asia.
I am a member of the consultation board of the Israeli Cancer Society and an active member of some committees
And a member of the national Oncological advisory board
I am a member of several national and international societies wrote more than 100 articles and book chapters, and several hundred presentations at international meetings most of them as an invited speaker.
Dr. Karla Sepulveda is a Professor of Radiology at Baylor College of Medicine and Medical Director of Breast Imaging at Baylor St. Luke’s Medical Center in Houston. TX. She holds the Pat Korell Endowed Professorship of Breast Imaging. Dr. Sepulveda completed her fellowship in Breast Imaging at MD Anderson Cancer Center. She is active in the American College of Radiology and Texas Radiological Society and uses this work to advocate for high value, multidisciplinary care for breast cancer patients. Her areas of professional interest include healthcare innovation, the role of radiology in precision oncology, and applications of artificial intelligence in breast imaging.
Dr. Hassan Shahryar, is a consultant in medical oncology and hematology at the Sheikh Shakbout Medical City (SSMC) in partnership with Mayo Clinic and an adjunct clinical Associate Professor of Medicine at the Khalifa University in Abu Dhabi, UAE. He is Diplomate American Board of Internal Medicine, Geriatrics, Medical Oncology and Haematology. Dr. Shahryar practices general oncology in a large tertiary care public health system with a special interest in breast tumors. Dr. Shahryar is well published in peer reviewed international journals and is an invited speaker at the national and regional cancer conferences. He is a participant of the ESMO Leaders Generation Programme Asia 2022 and an active member of the ESMO Leadership Development Committee.
Dr. Archana Shetty MRCS, FRCS
Consultant Oncoplastic Breast Surgeon & Head Of The Department,
Mediclinic Parkview Hospital, Dubai
Adjunct Clinical Associate Professor, MBRU
Dr. Archana has more than 20 years’ experience from UK, UAE & India
She was Fully trained in the UK for 15 years.
Ex-consultant Oncoplastic breast surgeon at Peterborough hospital (UK).
Ex- Consultant Oncoplastic breast surgeon at Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
Ex- Consultant Oncoplastic breast surgery at Narayana Health, Bangalore, India
Dr Archana has been awarded the coveted Donald Mcneill Oncoplastic fellowship by the Association of Breast Surgeons UK.
Fellow of Royal College Of Surgeons, UK
Faculty at the Royal College of Surgeons of Edinburgh, UK
Reviewer for the Indian Journal of Surgical Oncology & Dubai Medical Journal
Dr. Archana has done extensive research at University College London on DNA replication markers as prognostic & predictive factors for breast cancer
Published papers in multiple peer reviewed journals
Invited as faculty in numerous international conferences.
Prof. Alastair Thompson graduated from the University of Edinburgh, UK with Distinction in Surgery and subsequently trained as a Clinician Scientist and Fellow of the Royal College of Surgeons of Edinburgh. In 2014 he moved from the position of Professor of Surgical Oncology, Clinical Lead for the Dundee Cancer Centre/Experimental Cancer Medicine Centre and Foundation Director of the Clinical Research Centre, Dundee, UK to the Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center in Houston, Texas, specializing in breast cancer.
Achievements to date include setting up and chairing the Breast Cancer Campaign Breast Tissue Bank Board for the UK and Eire, leading the 12,000 patient UK National Audit of Screen Detected DCIS and, for 5 years to 2014, chairing the UK National Cancer Research Institute, Breast Clinical Studies Group (with oversight of 120 academic and commercial clinical studies in breast cancer). He actively contributes to a range of clinical trials in the prevention, early detection and therapy of breast cancer. He remains as UK Chief Investigator for a number of key trials including MINDACT, MA32 and SOLE and continues to chair the data monitoring committees and trials steering groups for several phase II drug trials and phase III surgical trials respectively in the UK.
Active in translational laboratory research, he built a breast cancer research program over 15 years in Dundee, including a xenograft program and tissue banking facility with a focus on the p53 network and drug development. He has successfully supervised 20 PhD or research MD students and currently has 4 students completing PhDs. The impact of over 200 peer reviewed research papers has included global firsts demonstrating the effect of drugs in vivo in animal models and in human cancers.
He continues to provide leadership in trials and clinical translational research with colleagues in Europe and Australasia while establishing clinical trials and laboratory collaborations in the US, through membership of the American Society of Clinical Oncology, American Association of Cancer Research, South West Oncology Group and Translational Breast Cancer Research Consortium.
Sebastian Winocour
Sebastian Winocour, MD, MSc, FACS is a board-certified plastic surgeon who specializes in advanced techniques in breast cancer reconstruction. He is the interim chief of the Division of Adult Plastic Surgery at Baylor College of Medicine and the Section Chief of Plastic Surgery at Baylor St. Luke’s Medical Center in Houston, Texas. He completed his residency in Plastic Surgery at Mayo Clinic in Minnesota followed by a microsurgery fellowship at MD Anderson Cancer Center. He is a leading researcher in the field of plastic surgery, having authored over 100 manuscripts in high impact journals and has given over 50 podium presentations at national and international conferences.